Somaxon Pharmaceuticals Acquired For $25M
socalTECH
DECEMBER 11, 2012
San Diego-based Somaxon , a developer of treatments for insomnia, has been acquired by Pernix Therapeutics Holdings , in a deal worth $25M. Somaxon had 12 months net sales of approximately $11.7M Somaxon had 12 months net sales of approximately $11.7M Somaxon was represented by Stifel Nicolaus Weisel in the acquisition.
Let's personalize your content